Piershale Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-202
| Closed | -$9K | – | 124 |
|
2016
Q3 | $9K | Hold |
202
| – | – | 0.01% | 96 |
|
2016
Q2 | $10K | Hold |
202
| – | – | 0.01% | 91 |
|
2016
Q1 | $11K | Hold |
202
| – | – | 0.01% | 81 |
|
2015
Q4 | $13K | Hold |
202
| – | – | 0.01% | 101 |
|
2015
Q3 | $11K | Buy |
+202
| New | +$11K | 0.01% | 77 |
|
2015
Q2 | – | Sell |
-202
| Closed | -$13K | – | 144 |
|
2015
Q1 | $13K | Hold |
202
| – | – | 0.01% | 73 |
|
2014
Q4 | $12K | Hold |
202
| – | – | 0.01% | 95 |
|
2014
Q3 | $11K | Hold |
202
| – | – | 0.01% | 84 |
|
2014
Q2 | $11K | Hold |
202
| – | – | 0.01% | 97 |
|
2014
Q1 | $11K | Hold |
202
| – | – | 0.01% | 81 |
|
2013
Q4 | $8K | Hold |
202
| – | – | 0.01% | 74 |
|
2013
Q3 | $8K | Hold |
202
| – | – | 0.01% | 78 |
|
2013
Q2 | $8K | Buy |
+202
| New | +$8K | 0.02% | 64 |
|